Plus Therapeutics, Inc. (PSTV)

Plus Therapeutics Revenue

Plus Therapeutics had revenue of $1.06M in the quarter ending March 31, 2025, a decrease of -36.85%. This brings the company's revenue in the last twelve months to $5.21M, down -14.43% year-over-year. In the year 2024, Plus Therapeutics had annual revenue of $5.82M with 18.54% growth.

• Revenue (ttm): $5.21M
• Revenue Growth: -14.43%
• P/S Ratio: 1.29
• Revenue / Employee: $247,905
• Employees: 21
• Market Cap: 34.75M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	5.82M	911.00K	18.54%
Dec 31, 2023	4.91M	4.69M	2,093.30%
Dec 31, 2022	224.00K	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	303.00K	-6.70M	-95.67%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.